Sandrine Oziel-Taieb Jemima Maniry-Quellier Brice Chanez Flora Poizat Jacques Ewald Patricia Niccoli
10.3389/fendo.2022.860614
Front Endocrinol (Lausanne)
2022 Apr 19;13:860614.
malignant insulinoma neuroendocrine tumor pancreatic neuroendocrine cancer pasireotide refractory hypoglycemia
CC BY
https://pubmed.ncbi.nlm.nih.gov/35518928/
Hypoglycemia / drug therapy Hypoglycemia / etiology Insulinoma / complications Insulinoma / drug therapy Insulinoma / pathology Pancreatic Neoplasms / complications Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / pathology
Hypoglycemia / drug therapy Hypoglycemia / etiology Insulinoma / complications Insulinoma / drug therapy Insulinoma / pathology Pancreatic Neoplasms / complications Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / pathology Case Reports Review Female Humans Middle Aged Somatostatin / analogs & derivatives Somatostatin / therapeutic use Somatostatin pasireotide
PMC9063459
35518928
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature
2022